Method, apparatus and procedure for non-invasive monitoring blood glucose by measuring the polarization ratio of blood luminescence

• US 5,383,452 A
• Filed: 07/01/1993
• Issued: 01/24/1995
• Est. Priority Date: 07/01/1993
• Status: Expired due to Fees

• Current Assignee: Janusz Buchert
• Original Assignee: Janusz Buchert
• Inventors: Buchert, Janusz
• Primary Examiner(s): Cohen, Lee S.
• Assistant Examiner(s): NASSER, ROBERT L
• Application Number:
  US08/086,236
• Time in Patent Office: 572 Days
• Field of Search: 128/633, 128/664-666, 128/653.1, 356/41
• US Class Current: 600/347
• CPC Class Codes: A61B 5/14558 by polarisation

Abstract

A method, apparatus and procedure for the non-invasive detection of the sugar concentration changes in body liquids such as blood is disclosed. The instrument measures sugar concentration changes using the natural fingerprint of sugar which is rotations of polarization of light emitted from the biological particle chromophores dissolved together with sugar in human liquids. The degree of polarization of light emitted from luminescence centers undergoing interaction with an optically active medium such as sugar is proportional to the concentration of sugar in, for example, blood. The reference level is determined by conventional blood analysis using standard monitoring equipment during the special procedure of the Glucose Tolerance Test.

Claims

1. A method of determining blood glucose concentration from non-invasive measurements of a state of polarization of light emitted by a luminescing center of blood which are dissolved and/or attached to optically active molecules of sugar and upon interaction rotate the initial polarization comprising:

a. illuminating sample tissue with a beam with linearly or circularly polarized light,

b. said light having a wavelength absorbed by blood constituents,

c. detecting emitted luminescence light from the tissue at a predetermined emission wavelength,

d. analyzing the state of polarization of said emitted light,

e. correlating the state of emitted light polarization with blood glucose concentration.

2. An instrument for non-invasive blood glucose measurements based on a state of polarization of native luminescence from blood comprising:

a. means for illuminating a blood carrying tissue with a beam of monochromatic, polarized light, and causing the blood in said tissue to emit native luminescence light,

b. means for detecting said emitted native luminescence light from the blood at a predetermined wavelength,

c. means for detecting the state of polarization of the emitted native luminescence light from the blood, and

d. means for correlating the polarization state of the emitted native luminescence light from said blood with blood glucose concentration.

3. The instrument of claim 2, wherein the illuminating means includes light source means for emitting a beam of light, polarizing means for polarizing the emitted light, and focusing means for focusing the polarized light on said blood carrying tissue.

4. The instrument of claim 3, wherein the light source means is selected from the group consisting of lasers, light emitting diodes, and lamp light sources.

5. The instrument of claim 2, wherein the detecting means comprises analyzing means for receiving the emitted native luminescence light from the blood, photodetector means for detecting the received native luminescence light from said analyzing means and producing an output signal, focusing means for focusing the received native luminescence light on the photodetector means, and wavelength selecting means for allowing only wavelengths of the emitted native luminescence light to reach the photodetector means.

6. The instrument of claim 5, wherein the photodetector means is selected from the group consisting of photodiodes and photomultipliers.

7. The instrument of claim 2, wherein the detecting means comprises filter means for filtering the output signal from the photodetector means for allowing only signals at a heart rate frequency to pass and amplification means for amplifying the passed signals at the heart rate frequency.

8. The instrument of claim 7, wherein the amplification means is an electronic amplifier.